Loading clinical trials...
Loading clinical trials...
Phase III, multicentre, double-blind, randomised, parallel, equivalence clinical trial to determine the efficacy, safety and immunogenicity of Megalabs® recombinant human alfa epoetin for intravenous ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Megalabs
NCT05515367 · Chronic Kidney Diseases, Anemia of Chronic Kidney Disease
NCT05082584 · Anemia of Chronic Kidney Disease
NCT06556134 · Anemia of Chronic Kidney Disease
NCT05900635 · Anemia of Chronic Kidney Disease
NCT04667533 · Anemia of Chronic Kidney Disease, Chemotherapy Effect
Megalabs
Colonia Nicolich, Departamento de Canelones
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions